HABERMAN ASSOCIATES
Haberman Associates provides technology and science strategy consulting for pharma and biotech companies.
HABERMAN ASSOCIATES
Industry:
Biotechnology Consulting Life Science
Founded:
1993-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.biopharmconsortium.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Lacerta Bio
Lacerta Bio is a business development and licensing consultancy for the pharma/biotech industry.
Pharmavise
Pharmavise provides regulatory compliance and manufacturing science & technology consulting for the Life Sciences industry
Official Site Inspections
http://www.biopharmconsortium.com
- Host name: mi3-tr100.supercp.com
- IP address: 70.32.23.100
- Location: Ann Arbor United States
- Latitude: 42.2503
- Longitude: -83.8393
- Metro Code: 505
- Timezone: America/Detroit
- Postal: 48106
More informations about "Haberman Associates"
Biotechnology, Pharmaceutical, Life Science Consulting
As reported in the 18 April issue of the New England Journal of Medicine, researchers at the St. Jude Children’s Research Hospital (Memphis, TN) and their colleagues have used gene therapy to restore immune function to eight infants …See details»
BioPharma Consortium
The BioPharma Consortium Vision. A life science consortium that engages, serves and partners with biotech, pharma, medical device, academia, research institutes and special interest or …See details»
Meet The Biopharmaceutical Consortium Members
SciGro, Inc. Betsy Ohlsson-Wilhelm Ph.D. and Katharine Muirhead, Ph.D., Principals. SciGro, Inc., founded in 1996, specializes in services supporting …See details»
Biopharmaceutical Consortium - Haberman Associates
The Biopharmaceutical Consortium is an expert team formed in 1997 to assist life science companies, research groups, and emerging enterprises.. The Consortium’s goal is to identify …See details»
Meet Our Board - BioPharma Consortium
The BioPharma Consortium Board. Lisa Hagerty-McMahon (), President & Chairman of the BoardDeborah Ovadia (), Outreach and Promotions ChairMatthew Busse (), Information …See details»
BPC Collaborators — BioPharma Consortium
BioPharma Consortium Partners and Program Collaborators. Genentech; Novartis; JLABS; DLA Piper; Molecular Medicine Research Institute; Stanford; Society for Brain Mapping & …See details»
biopharmconsortium.com - Biotechnology, Pharmaceutical ... - Sur.ly
Biopharmconsortium.com. Boston based Life Science R&D and Partnering consulting specializing in science&technology strategy for biotechnology, pharmaceuti...See details»
Home - BioMaP-Consortium
Address new and emerging technologies, that enhance existing capabilities that increase the speed, quality, safety, yield, efficiency of the biomanufacturing process or the safety, …See details»
Biopharmconsortium Blog
Jun 5, 2010 We hope that you will continue to visit the Biopharmconsortium Blog at its new home, and to subscribe to our posts. We also welcome your constructive comments as …See details»
Associations - Canada
Associations are active in the Canadian life sciences sector at the national, provincial and regional levels. Canadian industry associations NationalSee details»
Cardiovascular Disease Archives - Haberman Associates
In our November 20, 2012 Biopharmconsortium Blog article, ... Aegerion intends to market lomitapide on its own, and is ramping up its marketing and sales organization in anticipation of …See details»
Biopharmconsortium Blog: ApoE4 and Alzheimer’s disease: …
In the December 15, 2009 issue of Neurology, a research report by Stephen Salloway and his colleagues at the Butler Hospital and Brown University (Providence, RI) and an editorial by …See details»
Contact — BioPharma Consortium
Contact. Questions? Comments? Concerns? Please contact us by completing the form to the right.See details»
Operational excellence in biopharma research and early …
1 day ago Training talent to be innovative should extend beyond core skill sets to enable sound judgment for trade-off decisions. Asset teams should prioritize activities by evaluating …See details»
Biology-driven drug discovery: a “disruptive innovation”?
In a blog published by Harvard Business School, Scott Anthony discussed Novartis’ R&D strategy as an example of “disruptive innovation”. Scott Anthony is president of Innosight, an innovation …See details»
Biopharmconsortium Blog - Haberman Associates
May 30, 2019 As reported in the 18 April issue of the New England Journal of Medicine, researchers at the St. Jude Children’s Research Hospital (Memphis, TN) and their colleagues …See details»
10 Best Biopharma Blogs & Websites in 2025
Jan 1, 2025 10 Best Biopharma Blogs ⋅ 1. BioPharma Dive ⋅ 2. Endpoints News ⋅ 3. BioPharm International ⋅ 4. BioPharma-Reporter » Biosimilars ⋅ 5. BioSpace News ⋅ 6. Biopharma Trend ⋅ …See details»
Haberman Associates - Crunchbase Company Profile & Funding
Haberman Associates provides technology and science strategy consulting for pharma and biotech companies.See details»
Biopharmconsortium Blog: Stapled peptides for targeting …
In the 12 November issue of Nature, there was a research article and a News and Views minireview about targeting an intracellular signaling pathway with a novel type of compound …See details»
MIT study finds that the probability of clinical trial success is ...
Mar 14, 2018 For example, as pointed out by Endpoints News, BIO (the Biotechnology Innovation Organization) in a recent publication analyzing clinical development success rate …See details»